Key result
De novo heart failure was associated with higher heart rate (p=0.029), diastolic BP (p=0.029), and systemic vascular resistance index (p=0.013) than acutely decompensated chronic heart failure.
Why the study?
Differences in clinical profiles between ADCHF and dnHF exist, but the hemodynamics related to both clinical states were not well recognized.
Do hemodynamic profiles differ between patients hospitalized with de novo heart failure versus acutely decompensated chronic heart failure?
Observational (n=102)
Do hemodynamic profiles differ between patients hospitalized with de novo heart failure versus acutely decompensated chronic heart failure?
De novo heart failure presents with greater tachycardia, vasoconstriction, and depressed cardiac performance compared to acutely decompensated chronic heart failure, with some unfavorable hemodynamics persisting at discharge.
dnHF shows distinct hemodynamics that may warrant tailored monitoring; observational data leaves open whether targeted interventions improve outcomes.
Background: Heart failure (HF) is associated with high mortality, morbidity, and frequent hospitalizations due to acute HF (AHF) and requires immediate diagnosis and individualized therapy. Some differences between acutely decompensated chronic heart failure (ADCHF) and de novo HF (dnHF) patients in terms of clinical profile, comorbidities, and outcomes have been previously identified, but the hemodynamics related to both of these clinical states are still not well recognized. Purpose: To compare patients hospitalized with ADCHF to those with dnHF, with a special emphasis on hemodynamic profiles at admission and changes due to hospital treatment. Methods: This study enrolled patients who were at least 18 years old, hospitalized due to AHF (both ADCHF and dnHF), and who underwent detailed assessments at admission and at discharge. The patients’ hemodynamic profiles were assessed by impedance cardiography (ICG) and characterized in terms of heart rate (HR), blood pressure (BP), systemic vascular resistance index (SVRI), cardiac index (CI), stroke index (SI), and thoracic fluid content (TFC). Results: The study population consisted of 102 patients, most of whom were men (76.5%), with a mean left ventricle ejection fraction (LVEF) of 37.3 ± 14.1%. The dnHF patients were younger than the ADCHF group and more frequently presented with palpitations (p = 0.041) and peripheral hypoperfusion (p = 0.011). In terms of hemodynamics, dnHF was distinguished by higher HR (p = 0.029), diastolic BP (p = 0.029), SVRI (p = 0.013), and TFC (only numeric, p = 0.194) but lower SI (p = 0.043). The effect of hospital treatment on TFC was more pronounced in dnHF than in ADCHF, and this was also true of N-terminal pro-brain natriuretic peptide (NT-proBNP) and body mass. Some intergroup differences in the hemodynamic profile observed at admission persisted until discharge: higher HR (p = 0.002) and SVRI (trend, p = 0.087) but lower SI (p < 0.001) and CI (p = 0.023) in the dnHF group. Conclusions: In comparison to ADCHF, dnHF is associated with greater tachycardia, vasoconstriction, depressed cardiac performance, and congestion. Despite more effective diuretic therapy, other unfavorable hemodynamic features may still be present in dnHF patients at discharge.
No takes yet. Share an insight, caveat, or question.
Galas et al. (2023) conducted an observational in Acute Heart Failure (n=102). De novo heart failure (dnHF) vs. Acutely decompensated chronic heart failure (ADCHF) was evaluated on Hemodynamic profiles at admission and changes due to hospital treatment. De novo heart failure was associated with higher heart rate (p=0.029), diastolic BP (p=0.029), and systemic vascular resistance index (p=0.013) than acutely decompensated chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: